Epistatic interaction of Arg72Pro TP53 and −710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survival

Gene-Gene and Gene-Environmental Interactions of Childhood Asthma: A Multifactor Dimension Reduction Approach

(2012) Ming-Wei Su et al.   PLoS One

Association between the p53 polymorphisms and breast cancer risk: meta-analysis based on case–control study

(2011) Xiao-Feng He et al.   BREAST CANCER RESEARCH AND TREATMENT

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Multiple Analytical Approaches Reveal Distinct Gene-Environment Interactions in Smokers and Non Smokers in Lung Cancer

(2011) Rakhshan Ihsan et al.   PLoS One

A Robust Multifactor Dimensionality Reduction Method for Detecting Gene-Gene Interactions with Application to the Genetic Analysis of Bladder Cancer Susceptibility

(2010) Jiang Gui et al.   ANNALS OF HUMAN GENETICS

No significant association between the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects

(2010) Yanlei Ma et al.   BREAST CANCER RESEARCH AND TREATMENT

Haplotype analysis of p53 polymorphisms: Arg72Pro, Ins16bp and G13964C in Tunisian patients with familial or sporadic breast cancer

(2010) Fatma Trifa et al.   Cancer Epidemiology

The role of TP53 and p21 gene polymorphisms in breast cancer biology in a well specified and characterized German cohort

(2010) Florian Ebner et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

P53 gene polymorphisms and breast cancer risk in Arab women

(2010) Shafika Alawadi et al.   MEDICAL ONCOLOGY

Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis

(2009) Zheng Hu et al.   BREAST CANCER RESEARCH AND TREATMENT

P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case–control studies

(2009) Zhizhong Zhang et al.   BREAST CANCER RESEARCH AND TREATMENT

Modes of p53 Regulation

(2009) Jan-Philipp Kruse et al.   CELL

Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls

(2009) Wenlei Zhuo et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: A case-control study

(2009) Henríquez-Hernández   ONCOLOGY REPORTS

Importance of TP53 codon 72 and intron 3 duplication 16bppolymorphisms in prediction of susceptibility on breast cancer

(2008) Sandra Costa et al.   BMC CANCER

Role of p53 Codon 72 Arginine Allele in Cell Survival in vitro and in the Clinical Outcome of Patients with Advanced Breast Cancer

(2008) I. Vannini et al.   TUMOR BIOLOGY